Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Volunteers needed for a study investigating the effects of a drug called “atomoxetine” on learning and memory. The drug, atomoxetine, is commonly used to treat ADHD

Atomoxetine on learning and memory

We are looking for healthy participants (both male and female), aged 18 to 35 years. In order to participate, you must be in good health with no history of neurological or psychiatric conditions.

The study consists of 2 study visits. The first study visit will take place at the Department of Psychiatry (Warneford Hospital), lasting 4-5 hours. On the first study visit you will be given a single dose of the drug called atomoxetine or a placebo treatment. After receiving either the drug or placebo treatment you will be asked to perform a computerised behavioural task. In addition, you will undergo an MRI scan, a type of non-invasive scan that allows us to see how the brain stores and uses memories. This scan is safe and does not involve any needles or injections. During the second study visit, you will perform computerized behavioural tasks, which will take about 1.5 hours.

After the last study session you will be reimbursed for your time.

Prior to your participation you will be asked questions about your medical history to check your suitability for the study, including whether it is safe for you to go in an MRI scanner.

If you are interested and would like more information, please contact Ms. Renée Koolschijn (renee.koolschijn@keble.ox.ac.uk) at the Wellcome Centre for Integrative Neuroimaging.

Ethics approval reference: RE60579/R004